Dapagliflozin reduces the risk of hospitalization in patients with chronic kidney disease
1. Dapagliflozin reduced the risk of hospitalization in patients with chronic kidney disease (CKD) with and without type 2 diabetes ...
1. Dapagliflozin reduced the risk of hospitalization in patients with chronic kidney disease (CKD) with and without type 2 diabetes ...
1. Compared to placebo, participants on aprocitentan had a greater reduction in office systolic blood pressure at four weeks and ...
1. In advanced-stage chronic kidney disease (CKD), there was no significant difference in long-term glomerular filtration rate (eGFR) between those ...
1. Supraphysiological oxygen administration during surgery is associated with higher incidence of kidney, myocardial and lung injury Evidence Rating Level: ...
1. There was no significant difference in the risk of cardiovascular-related death or hospitalization between the personalized cooler dialysate group ...
1. In this prospective cohort study, carbonate excretion levels in cystic fibrosis (CF) patients were correlated with various disease severity ...
1. Atezolizumab was associated with non-significantly increased disease-free survival compared to placebo (57.2 months vs. 49.5 months). 2. Serious adverse ...
1. In this post-hoc analysis of a randomized controlled trial, empagliflozin use in patients with heart failure (HF) was associated ...
1. Patients on fazirsiran had reductions in total liver misfolded alpha1-antitrypsin protein (Z-ATT). 2. All patients taking fazirsiran had histologic ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.